Who is Will Klein? Meet the Dodgers reliever who played hero in that marathon World Series Game 3 Jay-Z Isn't Convinced the ...

The bar for product differentiation and commercial viability has never been higher. Efficiency, external collaboration, and ...

Laramie startups are turning University of Wyoming research into products like natural mouthwash and kidney stone supplements ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

California VC firm Aditum Bio is at it again, this time partnering up with China-based Mabwell Bioscience to launch a new biotech focused on cardiovascular disease. Aditum has paid Mabwell $12 million ...

Excellergy is developing medicines that combat allergic responses in three different ways, a multipronged effect the company ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

The two recent announcements by FDA and NIH are the catalyst needed to jump start biotech productivity through the adoption of New Approach Methodologies (NAMs): These announcements build upon more ...

Bahrain Mumtalakat Holding Co. BSC(c), the sovereign wealth fund of the Kingdom of Bahrain, and SandboxAQ, which is focused ...

Virtus LifeSci Biotech Clinical Trials ETF BBC is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 138.3% from its 52-week low price of $13.42/share.

Jack Hidary, CEO of SandboxAQ, added: "We are honored to partner with Mumtalakat and the Kingdom of Bahrain to catalyze a new IP-generating biotech economy. Our collaboration will harness the power of ...